"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents"
2011320 pages
Springer·1 editions
Loading Description
Tags
NewBookshelves
0 readersNo users with this book on their shelves. Maybe you could be the first.
Threads
0 discussionsQuotes
0 quotesReviews
0 reviewsNo reviews yet. Add your review.
Lists
0 listsNo lists containing this book.
Purchasable Editions
1 editionsThe Amazon links are affiliate links
"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents" (2011)
"Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents" (2011)
Springer
Springer
paperback
ISBN 10: 1461288886
ISBN 13: 9781461288886